Bearish On Large Cap Pharma Stocks: Surjit Pal

Surjit Pal, pharma sector analyst at Prabhudas Lilladher, said that in the near to medium term, large cap pharma shares are not likely to achieve the kind of growth they had clogged in the last 5-6 years.